ALK and neuroblastoma: To identify additional malignancies beyond neuroblastoma with the potential for application of ALK-directed immunotherapeutic approaches, we first analyzed publicly available RNA sequencing data from the Tumor Compendium v11 of UCSC Treehouse Childhood Cancer initiative and from The Genotype-Tissue Expression Project v8 for neoplastic and normal tissues, respectively.